Evidence map›Paper›PMID 39919802›Full record

ArticleLife science alliance2025

PICH impacts the spindle assembly checkpoint via its DNA translocase and SUMO-interaction activities.

Bunu Lama, Hyewon Park, Anita Saraf, Victoria Hassebroek, Daniel Keifenheim, Tomoko Saito-Fujita, Noriko Saitoh, Vasilisa Aksenova, Alexei Arnaoutov, Mary Dasso and 2 more

Abstract read
In one paragraph

Article in Life science alliance, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Bunu LamaDepartment of Molecular Biosciences, University of Kansas, Lawrence, KS, USA.
Hyewon ParkDepartment of Molecular Biosciences, University of Kansas, Lawrence, KS, USA.
Anita SarafMass Spectrometry and Analytical Proteomics Laboratory, University of Kansas, Lawrence, KS, USA.
Victoria HassebroekDepartment of Molecular Biosciences, University of Kansas, Lawrence, KS, USA.
Daniel KeifenheimDepartment of Genetics, Cell Biology and Development, University of Minnesota, Minneapolis, MN, USA.
Tomoko Saito-FujitaDivision of Cancer Biology, The Cancer Institute of Japanese Foundation for Cancer Research, Tokyo, Japan.
Noriko SaitohDivision of Cancer Biology, The Cancer Institute of Japanese Foundation for Cancer Research, Tokyo, Japan.ORCID 0000-0002-2601-2806
Vasilisa AksenovaDivision of Molecular and Cellular Biology, National Institute for Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA.
Alexei ArnaoutovDivision of Molecular and Cellular Biology, National Institute for Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA.
Mary DassoDivision of Molecular and Cellular Biology, National Institute for Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA.ORCID 0000-0002-5410-1371
Duncan J ClarkeDepartment of Genetics, Cell Biology and Development, University of Minnesota, Minneapolis, MN, USA.ORCID 0000-0002-7795-3294
Yoshiaki AzumaDepartment of Molecular Biosciences, University of Kansas, Lawrence, KS, USA azumay@ku.edu.ORCID 0000-0002-9634-6676

Funding

Mentoring CoreP20GM103418 · NIGMS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI Douglas E Wright · 2012 to 2026
$63.0M
SUMO family Ubiquitin-like Modifiers In Higher EukaryotesZIAHD001902 · NICHD · EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT · PI DASSO, MARY C. · 2009 to 2021
$6.3M
Control of Chromosome Segregation by DNA Topoisomerase IIR01GM130858 · NIGMS · UNIVERSITY OF MINNESOTA · PI DUNCAN J. CLARKE · 2019 to 2026
$2.2M
Regulation of kinetochore function by Topoisomerase IIR01GM112793 · NIGMS · UNIVERSITY OF KANSAS LAWRENCE · PI AZUMA, YOSHIAKI, CLARKE, DUNCAN J. · 2015 to 2018
$1.2M
A high-throughput screen for inhibitors of Plk1-interacting checkpoint helicase (PICH)R21CA259718 · NCI · UNIVERSITY OF MINNESOTA · PI AZUMA, YOSHIAKI, CLARKE, DUNCAN J. · 2022 to 2023
$402k
Intramural NIH HHS ZIA HD001902NCI NIH HHS R21 CA259718NIGMS NIH HHS P20 GM103418NIGMS NIH HHS R01 GM112793NIGMS NIH HHS R01 GM130858
6 · The paper itself

Abstract

Either inhibiting or stabilizing SUMOylation in mitosis causes defects in chromosome segregation, suggesting that dynamic mitotic SUMOylation of proteins is critical to maintain integrity of the genome. Polo-like kinase 1-interacting checkpoint helicase (PICH), a mitotic chromatin remodeling enzyme, interacts with SUMOylated chromosomal proteins via three

Indexed as

DNA HelicasesM Phase Cell Cycle CheckpointsCell Cycle ProteinsChromosome SegregationHeLa CellsHumansKinetochoresMitosisProtein Serine-Threonine KinasesProteomicsSmall Ubiquitin-Related Modifier ProteinsSpindle ApparatusSumoylationBUB1 protein, humanCell Cycle ProteinsDNA HelicasesERCC6L protein, humanProtein Serine-Threonine KinasesSmall Ubiquitin-Related Modifier Proteins

Identifiers

PMID39919802
PMCPMC11806350

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.